Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Cantor Fitzgerald
Boehringer Ingelheim

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022565

« Back to Dashboard

NDA 022565 describes ADVIL CONGESTION RELIEF, which is a drug marketed by Pfizer and is included in one NDA. It is available from three suppliers. Additional details are available on the ADVIL CONGESTION RELIEF profile page.

The generic ingredient in ADVIL CONGESTION RELIEF is ibuprofen; phenylephrine hydrochloride. There are sixty-four drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ibuprofen; phenylephrine hydrochloride profile page.

Summary for 022565

Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 022565

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADVIL CONGESTION RELIEF ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022565 NDA Wyeth Consumer Healthcare LLC 0573-0195 0573-0195-01 50 POUCH in 1 TRAY (0573-0195-01) > 1 TABLET, FILM COATED in 1 POUCH
ADVIL CONGESTION RELIEF ibuprofen; phenylephrine hydrochloride TABLET;ORAL 022565 NDA Pfizer Consumer Healthcare 0573-0199 0573-0199-11 10 BLISTER PACK in 1 CARTON (0573-0199-11) > 1 TABLET, COATED in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength200MG;10MG
Approval Date:May 27, 2010TE:RLD:Yes

Expired Orange Book Patents for NDA: 022565

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
PfizerADVIL CONGESTION RELIEFibuprofen; phenylephrine hydrochlorideTABLET;ORAL022565-001May 27, 2010► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: